Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hepatic Encephalopathy × Glucose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hepatic Encephalopathy 1 Head and Neck Neoplasms 1 Emergencies 1 Critical Illness 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

phenylacetic acid 1 ammonul 1 Sodium Benzoate 1 Glucose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Amgen

Phase 2 Terminated

Hepatic Encephalopathy, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡